Skip to main content
PMC home page
Clinical Cardiology logoLink to Clinical Cardiology
. 2009 Feb 3;23(8):608–614. doi: 10.1002/clc.4960230812

Left ventricular myocardial remodeling and contractile state in chronic aortic regurgitation

Kazuhiro Taniguchi 1,✉, Tomohide Kawamaoto 2, Satoru Kuki 3, Takahumi Masai 3, Masataka Mitsuno 4, Susumu Nakano 4, Yasunaru Kawashima 4, Hikaru Matsuda 4
PMCID: PMC6654784  PMID: 10941548

Abstract

Background: In chronic aortic regurgitation, eccentric hypertrophy, with combined concentric hypertrophy of the left ventricle, is an important adaptive response to volume overload, which in itself is a compensatory mechanism for permitting the ventricle to normalize its afterload and to maintain normal ejection performance (physiologic hypertrophy). However, progressive dilatation of the left ventricle leads to depressed left ventricular (LV) contractility and myocardial structural changes, including cellular hypertrophy and interstitial fibrosis (pathological hypertrophy).

Hypothesis: The study was undertaken to determine the relationship between left ventricular myocardial structure and contractile function in 14 patients with chronic aortic regurgitation by cardiac catheterization and endomyocardial biopsies.

Methods: Myocardial cell diameter and percent interstitial fibrosis were obtained from biopsy samples. Contractile function was evaluated from the ratio of end‐systolic wall stress to end‐systolic volume index (ESS/ESVI) and the ejection fraction‐end‐systolic stress (EF‐ESS) relationship, which was obtained from 30 normal control subjects.

Results: Myocardial cell diameter correlated significantly with the ESVI (r = 0.72, p< 0.005), ejection fraction (r = −0.58, p<0.05), and ESS/ESVI (r = −0.58, p<0.05). The percent interstitial fibrosis also correlated inversely with ESS/ESVI (r = −0.71, p< 0.005). Compared with very few patients with an ESVI <70 ml/m2, the majority of patients with ESVI ≥ 70 ml/m2 had a cell diameter of ≥30 m̈m and a percent interstitial fibrosis of ≥l0%. The nine patients who had depressed contractile function, as assessed from the EF‐ESS relationship, had a higher percent interstitial fibrosis (p <0.05) than five patients showing a normal EF‐ESS relationship, despite the fact that there was no significant difference in myocardial cell diameter between them. Thus, advanced cellular hypertrophy and excessive interstitial fibrosis were significantly and independently associated with myocardial contractile dysfunction and appeared to be responsible for ventricular remodeling.

Conclusion: Our findings suggest that in many patients with aortic regurgitation, eccentric hypertrophy changes its nature from physiologic to nonphysiologic during the earlier stages in the course of the disease rather than during the stage described previously.

Keywords: aortic regurgitation, myocardial structure, contractile function, left ventricular hypertrophy, myocardial fibrosis, ventricular remodeling

Full Text

The Full Text of this article is available as a PDF (709.4 KB).

References

  • 1. Grossman W: Cardiac hypertrophy: Useful adaptation or pathologic process? Am J Med 1980; 69: 576–584 [DOI] [PubMed] [Google Scholar]
  • 2. Ross J Jr: Afterload mismatch in aortic and mitral valve disease: Implications for surgical therapy. J Am Coll Cardiol 1985; 5: 811–826 [DOI] [PubMed] [Google Scholar]
  • 3. Wisenbaugh T, Booth D, DeMaria A, Nissen S, Waters J: Relationship of contractile state to ejection performance in patients with chronic aortic valve disease. Circulation 1986; 73: 47–53 [DOI] [PubMed] [Google Scholar]
  • 4. Taniguchi K, Nakano S, Kawashima Y, Sakai K, Kawamoto T, Sakaki S, Kobayashi J, Morimoto S, Matsuda H: Left ventricular ejection performance, wall stress, and contractile state in aortic regurgitation before and after aortic valve replacement. Circulation 1990; 82: 798–807 [DOI] [PubMed] [Google Scholar]
  • 5. Devereux RB, Reichek N: Left ventricular hypertrophy. Cardiovasc Rev Rep 1980; 1: 55–68 [Google Scholar]
  • 6. Donaldson RM, Florio R, Rickards AF, Bennett JG, Yacoub M, Ross DN, Olsen E: Irreversible morphological changes contributing to depressed cardiac function after surgery for chronic aortic regurgitation. Br Heart J 1982; 48: 589–597 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 7. Panidis IP, Kotler MN, Ren JF, Mintz DS, Ross J, Kalman P: Development and regression of left ventricular hypertrophy. J Am Coll Cardiol 1984; 3: 1309–1320 [DOI] [PubMed] [Google Scholar]
  • 8. Krayenbuehl HP, Hess OM, Schneider J, Turina M: Left ventricular function and myocardial structure in aortic valve disease before and after surgery. Herz 1984; 9: 270–278 [PubMed] [Google Scholar]
  • 9. Schwarz F, Flameng W, Schaper J, Landebartels F, Sesto M, Hehrlein F, Schlepper M: Myocardial structure and function in patients with aortic valve disease and their relation to postoperative results. Am J Cardiol 1978; 41: 661–669 [DOI] [PubMed] [Google Scholar]
  • 10. Weber KT, Brilla CG: Pathological hypertrophy and cardiac interstitium. Fibrosis and renin‐angiotensin‐aldosteron system. Circulation 1991; 83: 1849–1865 [DOI] [PubMed] [Google Scholar]
  • 11. Weber KT, Brilla CG: Structural basis for pathologic left ventricular hypertrophy. Clin Cardiol 1993; 16 (suppl II): II‐10–II‐4 [DOI] [PubMed] [Google Scholar]
  • 12. Liu SK, Magid NR, Fox PR, Goldfine SM, Borer JS: Fibrosis, myocyte degeneration and heart failure in chronic experimental aortic regurgitation. Cardiology 1998; 90: 101–109 [DOI] [PubMed] [Google Scholar]
  • 13. Rackley CE, Dodge HT, Coble YD Jr, Hay RE: A method for determining left ventricular mass in man. Circulation 1964; 29: 666–671 [DOI] [PubMed] [Google Scholar]
  • 14. Mirsky I: Elastic properties of the myocardium: A quantitative approach with physiological and clinical applications In Handbook of Physiology, Section 2: The Cardiovascular System, Volume I (Ed. Berne RM.), p 497–531. Washington, DC: American Physiological Society, 1979. [Google Scholar]
  • 15. Hugenholtz PA, Kaplan E, Hall E: Determination of left ventricular wall thickness by angiocardiography. Am Heart J 1969; 78: 513–522 [DOI] [PubMed] [Google Scholar]
  • 16. Carabello BA, Nolan SP, McGuire LB: Assessment of preoperative left ventricular function in patients with mitral regurgitation: Value of the end‐systolic wall stress‐end‐systolic volume ratio. Circulation 1981; 64: 1212–1217 [DOI] [PubMed] [Google Scholar]
  • 17. Chalkley HW, Cornfield J, Park H: A method of estimating volume‐surface ratios. Science 1949; 110: 295–297 [DOI] [PubMed] [Google Scholar]
  • 18. Arai S, Machida A, Nakamura T: Myocardial structure and vascularization of hypertrophied hearts. Tohoku J Exp Med 1968; 95: 35–54 [DOI] [PubMed] [Google Scholar]
  • 19. Unverferth DV, Fetters JK, Unverferth BJ, Leier V, Magorien RD, Arn AR, Baker PB: Human myocardial histologic characteristics in congestive heart failure. Circulation 1983; 68: 1194–1200 [DOI] [PubMed] [Google Scholar]
  • 20. Krayenbuehl HP, Hess OM, Monrad ES, Schneider J, Mall G, Turina M: Left ventricular myocardial structure in aortic valve disease before, intermediate, and late after aortic valve replacement. Circulation 1989; 79: 744–755 [DOI] [PubMed] [Google Scholar]
  • 21. Schwarz F, Flameng W, Schaper J, Hehrlein F: Correlation between myocardial structure and diastolic properties of the heart in chronic aortic valve disease: Effects of corrective surgery. Am J Cardiol 1978; 42: 895–903 [DOI] [PubMed] [Google Scholar]
  • 22. Bonow RO, Carabello B, de Leon AC Jr, Edmunds LH Jr, Fedderly BJ, Freed MD, Gaasch WH, McKay CR, Nishimura RA, O'Gara PT, O'Rourke RA, Rahimtoola SH: ACC/AHA guidelines for the management of patients with valvular heart disease: A report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (Committee on Management of Patients with Valvular Heart Disease). J Am Coll Cardiol 1998; 32: 1486–1588 [DOI] [PubMed] [Google Scholar]
  • 23. Oldershow PJ, Brooksby IAB, Davies MJ, Coltart DJ, Jenkins BS, Webb‐Peploe MM: Correlation of fibrosis in myocardial biopsies from patients with aortic valve disease. Br Heart J 1980; 44: 609–611 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 24. Magid NM, Wallerson DC, Borer JS, Mukherjee A, Young MS, Devereux RB, Carter JN: Left ventricular diastolic and systolic performance during chronic experimental aortic regurgitation. Am J Physiol 1992; 23: H226–H233 [DOI] [PubMed] [Google Scholar]
  • 25. Magid NM, Opio G, Wallerson DC, Young MS, Borer JS: Heart failure due to chronic experimental aortic regurgitation. Am J Physiol 1994; 267:H556–H562 [DOI] [PubMed] [Google Scholar]
  • 26. Baandrup U, Florio RA, Olsen EGJ: Do endomyocardial biopsies represent the morphology of the rest of the myocardium? Eur Heart J 1982; 3: 171–178 [DOI] [PubMed] [Google Scholar]
  • 27. Schoen FJ, Lawrie GM, Titus JL: Left ventricular cellular hypertrophy in pressure‐ and volume‐overload valvular heart disease. Hum Pathol 1984; 15: 860–865 [DOI] [PubMed] [Google Scholar]
  • 28. Scognamiglio R, Rahimtoola SH, Fasoli G, Nistri S, Dalla Volta S: Nifedipine in asymptomatic patients with severe aortic regurgitation and normal left ventricular function. N Engl J Med 1994; 331: 689–694 [DOI] [PubMed] [Google Scholar]
  • 29. Cohn JN: Structural basis for heart failure. Ventricular remodeling and its pharmacological inhibition. Circulation 1995; 91: 2504–2507 [DOI] [PubMed] [Google Scholar]
  • 30. Assey MA, Spann JF Jr: Indications for heart valve replacement. Clin Cardiol 1990; 13: 81–88 [DOI] [PubMed] [Google Scholar]
  • 31. Bonow RO, Lakatos E, Maron BJ, Epstein SE: Serial long‐term assessment of the natural history of asymptomatic patients with chronic aortic regurgitation and normal left ventricular systolic function. Circulation 1991; 84: 1625–1635 [DOI] [PubMed] [Google Scholar]
  • 32. Tornos MP, Olona M, Permanyer‐Miralda G, Herrejon P, Camprecios M, Evangelista A, Garcia del Castill H, Candell J, Soler‐Soler J: Clinical outcome of severe asymptomatic chronic aortic regurgitation: A long‐term prospective follow‐up study. Am Heart J 1995; 130: 333–339 [DOI] [PubMed] [Google Scholar]
  • 33. Ishii K, Hirota Y, Suwa M, Kita Y, Onaka H, Kawamura K: Natural history and left ventricular response in chronic aortic regurgitation. Ami Cardiol 1996; 78: 357–361 [DOI] [PubMed] [Google Scholar]
  • 34. Klodas E, Enriquez SM, Tajik AJ, Mullany CJ, Bailey KR, Seward JB: Optimizing timing of surgical correction in patients with severe aortic regurgitation: Role of symptoms. J Am Coll Cardiol 1997; 30: 746–752 [DOI] [PubMed] [Google Scholar]

Articles from Clinical Cardiology are provided here courtesy of Wiley

RESOURCES